FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387568637> ?p ?o ?g. }

• W4387568637 endingPage "2771" @default.
• W4387568637 startingPage "2771" @default.
• W4387568637 abstract "Perillyl alcohol (PA), a naturally existing monocyclic terpene related to limonene, is characterized by its poor aqueous solubility and very limited bioavailability. Its potential anti-cancer activity against malignant glioma has been reported. The aim was to develop PA-loaded lipid-based nanocarriers (LNCs), and to investigate their anti-cancer activity against two different brain cell lines. Non-medicated and PA-loaded LNCs were prepared and characterized. The mechanism of cytotoxic activity of PA was conducted using a molecular docking technique. The cell viabilities against A172 and ANGM-CSS cells were evaluated. The results revealed that the average particle size of the prepared LNCs ranged from 248.67 ± 12.42 to 1124.21 ± 12.77 nm, the polydispersity index was 0.418 ± 0.043–0.509 ± 0.064, while the zeta potential ranged from −36.91 ± 1.31 to −15.20 ± 0.96 mV. The molecular docking studies demonstrated that the drug had binding activity to human farnesyltransferase. Following exposure of the two glioblastoma cell lines to the PA-loaded nanoformulations, MTS assays were carried out, and the data showed a far lower half-maximal inhibitory concentration in both cell lines when compared to pure drug and non-medicated nanocarriers. These results indicate the potential in vitro antiproliferative activity of PA-loaded LNCs. Therefore, the prepared PA-loaded nanocarriers could be used to enhance drug delivery across the blood–brain barrier (BBB) in order to treat brain cancer, especially when formulated in a suitable dosage form. The size, surface charge, and lipid composition of the LNCs make them promising for drug delivery across the BBB. Detailed pharmacokinetic and pharmacodynamic assessments, including the evaluation of BBB penetration, are necessary to better understand the compound’s distribution and effects within the brain." @default.
• W4387568637 created "2023-10-13" @default.
• W4387568637 creator A5007541697 @default.
• W4387568637 creator A5010490417 @default.
• W4387568637 creator A5012905296 @default.
• W4387568637 creator A5027144072 @default.
• W4387568637 creator A5028031616 @default.
• W4387568637 creator A5029658668 @default.
• W4387568637 creator A5034832635 @default.
• W4387568637 creator A5067839086 @default.
• W4387568637 creator A5077573067 @default.
• W4387568637 date "2023-10-12" @default.
• W4387568637 modified "2023-10-13" @default.
• W4387568637 title "Incorporation of Perillyl Alcohol into Lipid-Based Nanocarriers Enhances the Antiproliferative Activity in Malignant Glioma Cells" @default.
• W4387568637 cites W1264540065 @default.
• W4387568637 cites W1483551254 @default.
• W4387568637 cites W1522954291 @default.
• W4387568637 cites W1970835750 @default.
• W4387568637 cites W1976338808 @default.
• W4387568637 cites W1991332857 @default.
• W4387568637 cites W1996993122 @default.
• W4387568637 cites W1997250783 @default.
• W4387568637 cites W1998406048 @default.
• W4387568637 cites W2009109692 @default.
• W4387568637 cites W2010603143 @default.
• W4387568637 cites W2014446751 @default.
• W4387568637 cites W2015638235 @default.
• W4387568637 cites W2025847642 @default.
• W4387568637 cites W2031004252 @default.
• W4387568637 cites W2037087957 @default.
• W4387568637 cites W2043494568 @default.
• W4387568637 cites W2051078890 @default.
• W4387568637 cites W2063218844 @default.
• W4387568637 cites W2063606959 @default.
• W4387568637 cites W2067266635 @default.
• W4387568637 cites W2068288481 @default.
• W4387568637 cites W2071306094 @default.
• W4387568637 cites W2072991077 @default.
• W4387568637 cites W2088914699 @default.
• W4387568637 cites W2090977927 @default.
• W4387568637 cites W2092032912 @default.
• W4387568637 cites W2092638436 @default.
• W4387568637 cites W2102377211 @default.
• W4387568637 cites W2122910156 @default.
• W4387568637 cites W2125283587 @default.
• W4387568637 cites W2156768856 @default.
• W4387568637 cites W2207748390 @default.
• W4387568637 cites W2259653848 @default.
• W4387568637 cites W2317256715 @default.
• W4387568637 cites W2324956847 @default.
• W4387568637 cites W2330799739 @default.
• W4387568637 cites W2468997949 @default.
• W4387568637 cites W2474706751 @default.
• W4387568637 cites W2772216330 @default.
• W4387568637 cites W2804846127 @default.
• W4387568637 cites W2889450504 @default.
• W4387568637 cites W2898307391 @default.
• W4387568637 cites W2964203957 @default.
• W4387568637 cites W3008004285 @default.
• W4387568637 cites W3030526746 @default.
• W4387568637 cites W3094131058 @default.
• W4387568637 cites W3109746568 @default.
• W4387568637 cites W3139227215 @default.
• W4387568637 cites W3193476873 @default.
• W4387568637 cites W4200412805 @default.
• W4387568637 cites W4205471480 @default.
• W4387568637 cites W4225165989 @default.
• W4387568637 cites W4283803576 @default.
• W4387568637 cites W4309710749 @default.
• W4387568637 cites W4327739333 @default.
• W4387568637 cites W4385254754 @default.
• W4387568637 doi "https://doi.org/10.3390/biomedicines11102771" @default.
• W4387568637 hasPublicationYear "2023" @default.
• W4387568637 type Work @default.
• W4387568637 citedByCount "0" @default.
• W4387568637 crossrefType "journal-article" @default.
• W4387568637 hasAuthorship W4387568637A5007541697 @default.
• W4387568637 hasAuthorship W4387568637A5010490417 @default.
• W4387568637 hasAuthorship W4387568637A5012905296 @default.
• W4387568637 hasAuthorship W4387568637A5027144072 @default.
• W4387568637 hasAuthorship W4387568637A5028031616 @default.
• W4387568637 hasAuthorship W4387568637A5029658668 @default.
• W4387568637 hasAuthorship W4387568637A5034832635 @default.
• W4387568637 hasAuthorship W4387568637A5067839086 @default.
• W4387568637 hasAuthorship W4387568637A5077573067 @default.
• W4387568637 hasBestOaLocation W43875686371 @default.
• W4387568637 hasConcept C109316439 @default.
• W4387568637 hasConcept C155672457 @default.
• W4387568637 hasConcept C171250308 @default.
• W4387568637 hasConcept C178790620 @default.
• W4387568637 hasConcept C181389837 @default.
• W4387568637 hasConcept C18150654 @default.
• W4387568637 hasConcept C185592680 @default.
• W4387568637 hasConcept C192562407 @default.
• W4387568637 hasConcept C199529486 @default.
• W4387568637 hasConcept C202751555 @default.
• W4387568637 hasConcept C2778227246 @default.
• W4387568637 hasConcept C2779820397 @default.

• next